Olarte, Aiza .

HRN: 17-98-99  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/20/2024
CEFUROXIME 1.5GM (VIAL)
04/20/2024
04/27/2024
IV
1.5gram
Q8
S/P Ex Lap, Vaginal Exploration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: